Interim analysis of study OLN-356: Neoral versus Sandimmune in US primary liver transplant recipients. OLN-356 Principal Investigators.
Pinson
C W
CW
Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Transplant Center, Nashville, Tennessee 37232-4753, USA.
Beauregard-Zollinger
L
L
D000284:Administration, Oral; D000328:Adult; D016009:Chi-Square Distribution; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004304:Dosage Forms; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D014481:United States
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine